DOCSLIB.ORG

PUBLICATIONS 2. Hammond CB; Rock JA; Parker RT

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PUBLICATIONS 2. Hammond CB; Rock JA; Parker RT PUBLICATIONS Juried Journal Articles 1. Creasman WT; Rock JA; Cristakos AC; Parker RT: “Genital cytologic abnormalities in patients having therapeutic abortions.” South Med J 69(2):199-200, 1976. 2. Hammond CB; Rock JA; Parker RT: “Conservative treatment of endometriosis: the effects of limited surgery and hormonal pseudo pregnancy.” Fertil Steril 27(7):756-66, 1976. 3. Rock JA; Brame RG; Parker RT: “Choice of analgesia for pain relief of suction curettage.” Obstet Gynecol 49(6):721-3, 1977. 4. Rock JA; Jones HW, Jr.: “The clinical management of the double uterus.” Fertil Steril 28(8):798-806, 1977. 5. Rary JM; Cummings DK; Jones HW, Jr.; Rock JA; Julian CG: “Cytogenetic and clinical notes on a girl with 46,X,i(Yq) karyotype, H-Y antigen-negative and a gonadoblastoma.” Birth Defects, 14(6C):97-107, 1978. 6. Jones HW Jr.; Rock JA: “On the reanastomosis of fallopian tubes after surgical sterilization.” Fertil Steril 29(6):702-4, 1978. 7. Rock JA; Katayama KP; Martin EJ; Woodruff JD; Jones HW, Jr.: “Factors influencing the success of salpingostomy techniques for distal fimbrial obstruction.” Obstet Gynecol 52(5):591-6, 1978. 8. Babaknia A; Rock JA; Jones HW, Jr.: “Pregnancy success following abdominal myomectomy for infertility.” Fertil Steril 30:644-7, 1978. 9. Jones HW, Jr.; Park IJ; Rock JA: “Technique of surgical sex reassignment for micropenis and allied conditions.” Am J Obstet Gynecol 132(8):870-7, 1978. 10. Rary JM; Cummings DR; Jones HW, Jr.; Rock JA: “Assignment of the H-Y antigen gene to the short arm of the Y chromosome.” J Heredity 70(1):78-80, 1979. 11. Adashi EY; Rock JA; Sapp KC; Martin EJ; AC; Jones GS: “Gestational outcome of clomiphene-related conceptions.” Fertil Steril 31(6):620-6, 1979. 12. Rock JA; Katayama KP; Martin EJ; Rock BM; Woodruff JD; Jones HW, Jr.: “Pregnancy outcome following uterotubal implantation: a comparison of the reamer and sharp cornual wedge excision techniques.” Fertil Steril 31(6):634-40, 1979. 13. Rock JA; Rosenwaks Z; Adashi EY; Jones HW, Jr.; King TM: “Microsurgery for tubal reconstruction following Falope ring sterilization in swine.” J Microsurgery 1(1):61, 1979. John A. Rock, M.D. 2 ______________________________________________________________________________ 14. Jones HW Jr.; Rary JM; Rock JA; Cummings D: “The role of the H-Y antigen in human sexual development.” Johns Hopkins Med J 145(2):33-43, 1979. 15. Rock JA; Baramki T; Parmley TH; Jones HW, Jr.: “A unilateral functioning uterine anlage with mullerian duct agenesis.” Int J Gynaecol Obstet Gynecol 18(2):99-101, 1980. 16. Rock JA; Burkman R; King TM: “An international program for the assessment of tubal anastomosis by micro surgical technique: A preliminary report.” J Microsurg 2:63, 1980. 17. Rock JA; Jones HW, Jr.: “The double uterus associated with an obstructed hemivagina and ipsilateral renal agenesis.” Am J Obstet Gynecol 138(3):339-42, 1980. 18. Rock JA; Parmley TH; King TM; Laufe LE; Hsu B: “Endometriosis and the development of tubo-peritoneal fistula after tubal ligation.” Fertil Steril 35(1):16-20, 1981. 19. Hernandez E; Sapp KC; Rock JA: “Danazol in the treatment of recurrent or persistent endometriosis: A preliminary report.” Infertility 4(1):29, 1981. 20. Bergquist CA; Rock JA; Jones HW, Jr.: “Pregnancy outcome following treatment of intrauterine adhesions.” Int J Fertil 26(2):107-11, 1981. 21. Rock JA; Guzick DS; Sengos C; Schweditsch M; Jones HW, Jr.: “The conservative surgical treatment of endometriosis: evaluation of pregnancy success respect to the extent of disease as categorized using contemporary classification systems.” Fertil Steril 35(2):131-7, 1981. 22. Guzick DS; Rock JA: “Estimation of a model of cumulative pregnancy following infertility therapy.” Am J Obstet Gynecol 140(5):573-8, 1981. 23. Moore EE; Harger JH; Rock JA; Archer DF: “Management of pelvic endometriosis with low dose danazol.” Fertil Steril 36(1):15-9, 1981. 24. Adashi EY; Rock JA; Guzick DS; Wentz AC; Jones GS; Jones HW, Jr.: “Fertility following bilateral ovarian wedge resection: critical analysis of 90 consecutive cases of the polycystic ovary syndrome.” Fertil Steril 36(3):320-5, 1981. 25. Foster DC; Stern JL; Buscema J; Rock JA; Woodruff JD: “Pleural and parenchymal pulmonary endometriosis.” Obstet Gynecol 58(5):552-6, 1981. 26. Jones HW, Jr.; Lee PA; Rock JA; Migeon CJ: “A genetic male patient with 17-hydroxylase deficiency. “ Obstet Gynecol 59(2):254, 1982. 27. Jones HW, Jr.; Lee PA; Rock JA; Archer DF; Migeon CJ: “A genetic male patient with 17 alpha- hydroxylase deficiency,” Obstet Gynecol. 59(2):254-9, 1982. John A. Rock, M.D. 3 ______________________________________________________________________________ 28. Rock JA; Zacur HA; Dlugi AM; Jones HW, Jr.; TeLinde RW: “Pregnancy success following the surgical correction of imperforate hymen as compared to the complete transverse vaginal septum.” Obstet Gynecol 59:448-51, 1982. 29. Guzick DS; Bross D; Rock JA: “A parametric method for comparing cumulative pregnancy curves following infertility therapy.” Fertil Steril, 37(4):503-7, 1982. 30. Schuetz AW; Rock JA: “Stimulatory and inhibitory effects of human follicular fluid on amphibian oocyte maturation and ovulation in vitro.” Differentiation 21:41, 1982. 31. Lee PA; Rock JA; Brown TB; Fichman KM; Migeon CJ; Jones HW, Jr.: “Leydig cell hypo-function resulting in male pseudohermaphroditism.” Fertil Steril 37:675, 1982. 32. Rock JA; Bergquist CA; Zacur HA; Parmley TH; Guzick DS; Jones HW, Jr.: “Tubal anastomosis following unipolar cautery.” Fertil Steril 37(5):613-8, 1982. 33. Urban DJ; Henkle CW; Rock JA: “Nurse specialization in reproductive endocrinology.” JOGN Nursing, 11(3):167-70, 1982. 34. Rock JA; Dubin NH; Ghodgaonkar RB; Bergquist CA; Erozan YS; Kimball AW, Jr.: “Cul-de-sac fluid in women with endometriosis: fluid volume and prostanoid concentration during the proliferative phase of the cycle--days 8 to 12.” Fertil Steril 37:747-50, 1982. 35. Bergquist CA; Rock JA; Miller J; Guzick DS; Wentz AC; Jones GS: “Artificial insemination with fresh donor semen using cervical cap technique: A review of 278 cases.” Obstet Gynecol 60(2):195- 9, 1982. 36. Guzick DS; Bross D; Rock JA: “Assessing the efficacy of the American Fertility Society's classification of endometriosis: Application a dose-response methodology.” Fertil Steril 38(2):171, l982. 37. Rock JA; Rock WA, Jr.; Rary, J: “Testicular morphology in the 47XXY fetus 20 weeks gestation.” Int J Gynaecol Obstet 20:261, 1982. 38. Rock JA; Woodruff JD: “Surgical correction of a recto vaginal fistula.” Int J Gynaecol Obstet 20:413-6, 1982. 39. Berkovitz GD; Rock JA; Urban MD; Migeon CJ: “True hermaphroditism.” Johns Hopkins Med J 151:209-7, 1982. 40. Bergquist CA; Rock JA: “Grossesses Reiussies A La Suite De Reanastomose Tubaire Chez Des Patientes Prealablement Sterilisees Par Cauterisation.” Afr Med 21 (203):5132, 1982. John A. Rock, M.D. 4 ______________________________________________________________________________ 41. Rock JA; Zacur HA: “The clinical management of repeated early pregnancy wastage.” Fertil Steril. 39 (2):123-40, 1983. 42. Rock JA; Reeves LA; Retto H; Baramki TA; Zacur HA; Jones HW, Jr.: “Success following vaginal creation for mullerian agenesis.” Fertil Steril 39(6):809-13, 1983. 43. Stetten G; Rock JA: “A paracentric chromosomal inversion associated with repeated early pregnancy wastage.” Fertil Steril 40(1):124, 1983. 44. Rock JA; Guzick DS; Zacur HA; Jones HW, Jr.: “Accessory surgical intervention in conjunction with resection and fulguration of endometriosis.” Infertility 4(3):1983. 45. Guzick DS; Rock JA: “A comparison of danazol and conservative surgery for the treatment of infertility due to mild or moderate endometriosis.” Fertil Steril 40(5):580-4, 1983. 46. Michalak DP; Zacur HA; Rock JA; Woodruff JD: “Autoimmunity in a patient with 47XXX.” Obstet Gynecol 62:667-9, 1983. 47. Rock JA; Bergquist CA; Kimball AW, Jr.; Zacur HA; King TM: “Comparison of the operating microscope and loupe for micro surgical tubal anastomosis: A randomized clinical trial.” Fertil Steril 41(2):229-32, 1984. 48. Rock, JA: “An expandable surgical chamber for use in conditions of weightlessness.” Aviat Space Environ Med 55:403-4, 1984. 49. Rock JA; Schlaff W; Zacur HA; Jones HW, Jr.: “The clinical management of congenital absence of the uterine cervix.” Int J Gynaecol Obstet 22(3):231-5, 1984. 50. Rock JA; Chang YS; Limpaphayom K; Koetswang S; Moeloek FA; Guzick DS; Burkman RT; King TM: “Micro surgical tubal anastomosis: a controlled trial in four Asian centers.” Microsurg 5(2):95- 7, 1984. 51. Rock JA; Jones HW, Jr.: “Vaginal forms for dilatation and/or to maintain vaginal patency.” Fertil Steril 42(2):187-90, 1984. 52. Rock JA; Siegler AM; Meisel MB; Haney AF; Rosenwaks Z; Pardo-Vargas F; Kimball AW, Jr.: “The efficacy of postoperative hydrotubation: a randomized prospective multi center clinical trial.” Fertil Steril 42(3):373-6, 1984. 53. Rock JA; Fortnery SM: “Medical and surgical considerations for women in spaceflight.” Obstetrical & Gynecological Survey 39(8)525-35, 1984. 54. Foster GV; Zacur HA; Rock JA: “Hot flashes in postmenopausal women ameliorated by danazol.” Fertil Steril 45(3):401-4, 1985. John A. Rock, M.D. 5 ______________________________________________________________________________ 55. Rock JA; Schlaff WD: “The obstetric consequences of uterovaginal anomalies.” Fertil Steril. 43(5):681-92, 1985. 56. Rock JA; Zacur HA; Damewood MD; Schlaff WD; Gearhart J; Chang T; Schuetz A; Foster G; Smith BR; Rosenshein NB: “In Vitro fertilization and embryo transfer: The Johns Hopkins Hospital, Baltimore, Maryland.” Journal of In Vitro Fertilization and Embryo Transfer 2(2):110-2, 1985. 57. Rock JA; Wentz AC; Cole KA; Kimball AW, Jr.; Zacur HA; Jones GS; Early SR: “Fetal malformations following progesterone therapy during pregnancy: a preliminary report.” Fertil Steril 44(1):17-9, 1985. 58. Rock JA; Shirey RS; Braine HG; Ness PM; Kickler TS; Bias WB; Schlaff WD; Callan NA; Niebyl JR: “Plasmapheresis for the treatment of repeated early pregnancy wastage associated with anti-P.” Obstet Gynecol 66(3 Suppl):57S-60S, 1985.
Load more

Recommended publications
  • Pregnancy in Non-Communicating Unicornuate Uterus
    THIEME 640 Case Report Pregnancy in Non-Communicating Unicornuate Uterus: Diagnosis Difficulty and Outcomes – aCaseReport Gestação em útero unicorno não comunicante: dificuldadediagnósticaedesfechos– relato de caso Camila Silveira de Souza1 Gabriela Gindri Dorneles1 Giana Nunes Mendonça1 Caroline Mombaque dos Santos1 Francisco Maximiliano Pancich Gallarreta1 Cristine Kolling Konopka1 1 Department of Gynecology and Obstetrics, Universidade Federal de Address for correspondence Cristine Kolling Konopka, MD, PhD, Santa Maria, Santa Maria, Rio Grande do Sul, Brazil Universidade Federal de Santa Maria, Avenida Roraima, 1000, prédio 26, sala 1333, Camobi, 97105-900, Santa Maria, RS, Brazil Rev Bras Ginecol Obstet 2017;39:640–644. (e-mail: [email protected]). Abstract Approximately 1 in every 76,000 pregnancies develops within a unicornuate uterus with a rudimentary horn. Müllerian uterus anomalies are often asymptomatic, thus, the diagnosis is a challenge, and it is usually made during the gestation or due to its complications, such as uterine rupture, pregnancy-induced hypertension, antepartum, Keywords postpartum bleeding and intrauterine growth restriction (IUGR). In order to avoid ► uterus unnecessary cesarean sections and the risks they involve, the physicians should ► abnormalities consider the several approaches and for how long it is feasible to perform labor ► pregnancy induction in suspected cases of pregnancy in a unicornuate uterus with a rudimentary ► parturition horn, despite the rarity of the anomaly. This report describes a case of a unicornuate ► pregnancy uterus in which a pregnancy developed in the non-communicating rudimentary horn complications and the consequences of the delayed diagnosis. Resumo Aproximadamente 1 em cada 76 mil gestações se desenvolvem em útero unicorno sem comunicação com o colo uterino.
    [Show full text]
  • Pregnancy in a Unicornuate Uterus with Non-Communicating Rudimentary Horn: Diagnostic and Therapeutic Challenges
    Contents lists available at Vilnius University Press Acta medica Lituanica ISSN 1392-0138 eISSN 2029-4174 2020. Vol. 27. No 2, pp. 84–89 DOI: https://doi.org/10.15388/Amed.2020.27.2.6 Pregnancy in a Unicornuate Uterus with Non-Communicating Rudimentary Horn: Diagnostic and Therapeutic Challenges Ratko Delić Department of Obstetrics and Gynecology, General and Teaching Hospital Celje, Slovenia Abstract. Unicornuate uterus with non-communicating rudimentary horn is a type of congenital uterine abnormality that occurs as a consequence of the arrested development of one of the two Müllerian ducts. Patients with unicornuate uterus have increased incidence of obstetric and gynaecological complications. We present a report of a clinical case of a 28-years-old female, who was referred to the hospital for evalu- ation of her infertility. The patient reported primary infertility and inability to conceive after 3-year period of regular unprotected intercourse. Transvaginal ultrasound, along with the preoperative evaluation were completed; however, no anomalies or irregularities were reported. Combined diagnostic simultaneous laparoscopy and hysteroscopy were performed to establish the diag- nosis of unicornuate uterus with non-communicating rudimentary horn. The patient conceived spontaneously after diagnostic laparoscopy and hysteroscopy. During and after pregnancy, our patient and her child experienced numerous complications (cervical incompetence, acute chorioamnionitis, acute fetal distress, pneumonia, septic shock) and procedures (cer- vical cerclage, urgent cesarean section, intensive care unit treatment) without significant fetal or maternal compromise. Keywords: infertility, unicornuate uterus, pregnancy, cervical incompetence, sepsis Nėštumas vienaragėje gimdoje su rudimentiniu nesusijungusiu ragu Santrauka. Vienaragė gimda su rudimentiniu nesusijungusiu ragu yra įgimta makšties anomalija, atsiradusi sutrikus vieno iš dviejų Miulerio latakų vystymuisi.
    [Show full text]
  • Genetic Syndromes and Genes Involved
    ndrom Sy es tic & e G n e e n G e f Connell et al., J Genet Syndr Gene Ther 2013, 4:2 T o Journal of Genetic Syndromes h l e a r n a DOI: 10.4172/2157-7412.1000127 r p u y o J & Gene Therapy ISSN: 2157-7412 Review Article Open Access Genetic Syndromes and Genes Involved in the Development of the Female Reproductive Tract: A Possible Role for Gene Therapy Connell MT1, Owen CM2 and Segars JH3* 1Department of Obstetrics and Gynecology, Truman Medical Center, Kansas City, Missouri 2Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 3Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA Abstract Müllerian and vaginal anomalies are congenital malformations of the female reproductive tract resulting from alterations in the normal developmental pathway of the uterus, cervix, fallopian tubes, and vagina. The most common of the Müllerian anomalies affect the uterus and may adversely impact reproductive outcomes highlighting the importance of gaining understanding of the genetic mechanisms that govern normal and abnormal development of the female reproductive tract. Modern molecular genetics with study of knock out animal models as well as several genetic syndromes featuring abnormalities of the female reproductive tract have identified candidate genes significant to this developmental pathway. Further emphasizing the importance of understanding female reproductive tract development, recent evidence has demonstrated expression of embryologically significant genes in the endometrium of adult mice and humans. This recent work suggests that these genes not only play a role in the proper structural development of the female reproductive tract but also may persist in adults to regulate proper function of the endometrium of the uterus.
    [Show full text]
  • Reproductive MEDICINE Approximately One in Six Couples Will Experience Difficulty Conceiving
    reproductive MEDICINE Approximately one in six couples will experience difficulty conceiving. Our team can help. Welcome to the CMC Center for Reproductive Medicine at CMC Women’s Institute. From the moment you enter our office, you will experience the warm and welcoming atmosphere, the expert medical care and the success that truly makes the CMC Center for Reproductive Medicine one of the best centers in the region. Our physicians have over 50 years combined experience and are the only all board-certified Reproductive Endocrinology and Infertility team near Charlotte. Whether your infertility issue is simple or complex, our caring team will do everything it can to help you achieve your dream of having a baby. “The nurses are your biggest cheerleaders, and the doctors are your rock which helps you through to the next steps. Whenever I see my girls smile and giggle, every shot, test and office visit suddenly becomes a part of the story of how our family was created. There are no words to express my gratitude for the doctors and staff at CMC Center for Reproductive Medicine.” -Melissa Harrison Highly Trained When “high tech” treatment is needed, our physicians provide comprehensive care, seeking out the most effective new technologies with the best trained andrology and embryology specialists in the region. Our services include: Fertility Services • Intrauterine sperm inseminations (IUI) We believe that open communication is one of the most important elements of fertility • In vitro fertilization (IVF) treatment. This is why our entire staff is committed to listening to your concerns and • Donor egg program keeping you fully informed throughout your entire treatment plan.
    [Show full text]
  • Female Pelvic Relaxation
    FEMALE PELVIC RELAXATION A Primer for Women with Pelvic Organ Prolapse Written by: ANDREW SIEGEL, M.D. An educational service provided by: BERGEN UROLOGICAL ASSOCIATES N.J. CENTER FOR PROSTATE CANCER & UROLOGY Andrew Siegel, M.D. • Martin Goldstein, M.D. Vincent Lanteri, M.D. • Michael Esposito, M.D. • Mutahar Ahmed, M.D. Gregory Lovallo, M.D. • Thomas Christiano, M.D. 255 Spring Valley Avenue Maywood, N.J. 07607 www.bergenurological.com www.roboticurology.com Table of Contents INTRODUCTION .................................................................1 WHY A UROLOGIST? ..........................................................2 PELVIC ANATOMY ..............................................................4 PROLAPSE URETHRA ....................................................................7 BLADDER .....................................................................7 RECTUM ......................................................................8 PERINEUM ..................................................................9 SMALL INTESTINE .....................................................9 VAGINAL VAULT .......................................................10 UTERUS .....................................................................11 EVALUATION OF PROLAPSE ............................................11 SURGICAL REPAIR OF PELVIC PROLAPSE .....................15 STRESS INCONTINENCE .........................................16 CYSTOCELE ..............................................................18 RECTOCELE/PERINEAL LAXITY .............................19
    [Show full text]
  • 720Bfaa8bc7b73a78aff36ddef00
    MOLECULAR AND CLINICAL ONCOLOGY 12: 237-243, 2020 A comparative study on the short‑term clinical efficacy of the modified laparoscopic uterine comminution technique and traditional methods XIAOJUN SHI1, LIBING SHI2 and SONGYING ZHANG2 1Department of Gynecology, The First Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang 314001; 2Assisted Reproduction Unit, Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China Received April 28, 2019; Accepted December 13, 2019 DOI: 10.3892/mco.2020.1982 Abstract. To assess the value of the modified laparoscopic diagnosis and treatment. It has thus become one of the most uterine comminution technique in laparoscopic uterine surgery, commonly used techniques in the field of gynecology. Uterine a total of 82 cases of laparoscopic myomectomy were divided fibroids are common benign tumors of the female genital into the traditional group and modified group, according to organs and the prevalence has been reported as high as 20 to a random number table. During the same period, 92 patients 40% (1,2). The widespread application of pulverizers allows who underwent laparoscopic hysterectomy were divided into for removal of uterine fibroids under laparoscopy, which better the conventional group and the modified group, according to a reflects the superiority of minimally invasive techniques. random number table. The patients in the conventional group However, preoperative diagnosis of uterine fibroids and and modified group who underwent laparoscopic uterine uterine sarcoma is very difficult. The incidence of uterine fibroid removal showed no significant differences in the fibroid sarcoma is approximately 0.03 to 1.00% (3).
    [Show full text]
  • Reproductive Endocrinology and Infertility the American Board of Obstetrics and Gynecology, Inc
    1 2019 Bulletin for Subspecialty Certification in Reproductive Endocrinology and Infertility The American Board of Obstetrics and Gynecology, Inc. 2915 Vine St., Dallas, TX 75204 First in Women’s Health This Bulletin, issued in January 2018, represents the official statement of the 2019 requirements for subspecialty certification in Reproductive Endocrinology and Infertility 2 Important Information for all Candidates 1. Beginning in calendar year 2020, all physicians who have completed an ABOG or ACGME fellowship in Reproductive Endocrinology and Infertility must achieve ABOG subspecialty certification within 8 years of completion of their training. If certification is not achieved within 8 years, the physician no longer will be eligible to apply for either the qualifying or certifying subspecialty examination unless an additional 6 months of subspecialty training is completed. Physicians who have completed subspecialty training in calendar year 2012 or earlier must be subspecialty certified by 2020 or will be required to complete an additional 6 months of training before regaining eligibility to apply for certification. 2. The preparation of case lists for the Certifying Examination has changed. Candidates will no longer submit paper case lists. Rather, submission will be electronic. Candidates MUST use the electronic reproductive endocrinology and infertility case list forms that will be posted on their ABOG Personal Page in early 2018. 3. Fellows may take up to 8 weeks off each of the fellowship years. The total time off may not exceed 15 weeks over the three years. 4. All fees must be paid by credit card through the ABOG website (www.abog.org) and are payable in US Dollars only.
    [Show full text]
  • Pessary Information
    est Ridge obstetrics & gynecology, LLP 3101 West Ridge Road, Rochester, NY 14626 1682 Empire Boulevard, Webster, NY 14580 www.wrog.org Tel. (585) 225‐1580 Fax (585) 225‐2040 Tel. (585) 671‐6790 Fax (585) 671‐1931 USE OF THE PESSARY The pessary is one of the oldest medical devices available. Pessaries remain a useful device for the nonsurgical treatment of a number of gynecologic conditions including pelvic prolapse and stress urinary incontinence. Pelvic Support Defects The pelvic organs including the bladder, uterus, and rectum are held in place by several layers of muscles and strong tissues. Weaknesses in this tissue can lead to pelvic support defects, or prolapse. Multiple vaginal deliveries can weaken the tissues of the pelvic floor. Weakness of the pelvic floor is also more likely in women who have had a hysterectomy or other pelvic surgery, or in women who have conditions that involve repetitive bearing down, such as chronic constipation, chronic coughing or repetitive heavy lifting. Although surgical repair of certain pelvic support defects offers a more permanent solution, some patients may elect to use a pessary as a very reasonable treatment option. Classification of Uterine Prolapse: Uterine prolapse is classified by degree. In first‐degree uterine prolapse, the cervix drops to just above the opening of the vagina. In third‐degree prolapse, or procidentia, the entire uterus is outside of the vaginal opening. Uterine prolapse can be associated with incontinence. Types of Vaginal Prolapse: . Cystocele ‐ refers to the bladder falling down . Rectocele ‐ refers to the rectum falling down . Enterocele ‐ refers to the small intestines falling down .
    [Show full text]
  • Bicornuate Uterus with Unilateral Fibroid - Surgical Procedure Or LNG-IUS – a Conservative Approach in a Patient Who Opted LNG As Contraception
    Jemds.com Case Report Bicornuate Uterus with Unilateral Fibroid - Surgical Procedure or LNG-IUS – A Conservative Approach in a Patient Who Opted LNG as Contraception Ankita Yadav1, Shashi Prateek2, Latika Chawla3, Shailja Sharma4, Deepti Choudhary5 1Department of Obstetrics and Gynaecology, AIIMS Rishikesh, Dehradun, Uttarakhand, India. 2Department of Obstetrics and Gynaecology, AIIMS Rishikesh, Dehradun, Uttarakhand, India. 3Department of Obstetrics and Gynaecology, AIIMS Rishikesh, Dehradun, Uttarakhand, India. 4Department of Obstetrics and Gynaecology, AIIMS Rishikesh, Dehradun, Uttarakhand, India. 5Department of Obstetrics and Gynaecology, AIIMS Rishikesh, Dehradun, Uttarakhand, India INTRODUCTION Bicornuate uterus with leiomyoma is rare. A 30 - year - old patient with bicornuate Corresponding Author: uterus with fibroid presented with abnormal - uterine - bleeding and was treated non Dr. Latika Chawla, - surgically with LNG - IUS. Uterine fibroids and AUB affect the quality of life and Department of Obstetrics and Gynaecology, AIIMS Rishikesh-249203, remain a leading indication for hysterectomy. In young women, uterine preservation Dehradun, Uttarakhand, approaches should be preferred as far as possible. India. Abnormalities in fusion or formation of Mullerian duct results in uterine E-mail: [email protected] structural and functional abnormalities.1 One of the Mullerian duct anomalies, bicornuate uterus, occurs due to incomplete fusion of utero-vaginal horns at the level DOI: 10.14260/jemds/2020/640 of fundus. Bicornuate uterus is the most common Mullerian duct anomaly (25 % of cases )2,3 and association of bicornuate uterus with leiomyoma is very rare and there How to Cite This Article: Yadav A, Prateek S, Chawla L, et al. - have been very few cases reported till now.4,5 A case of bicornuate uterus with Bicornuate uterus with unilateral fibroid- unilateral fibroid is being reported who presented with abnormal uterine bleeding surgical procedure or lng- ius (a and pelvic pain and was treated non-surgically with LNG - IUS.
    [Show full text]
  • Obstetrics and Gyneclogy
    3/28/2016 Obstetrics and Gynecology Presented by: Peggy Stilley, CPC, CPC-I, CPMA, CPB, COBGC Objectives • Procedures • Pregnancy • Payments • Patient Relationships 1 3/28/2016 Female Genital Anatomy Terminology and Abbreviations • Endometriosis • Neoplasm • BUS • TAH/BSO • G3P2 2 3/28/2016 Procedures • Hysterectomy • Prolapse repairs • IUDs • Colposcopy Hysterectomy • Approach • Open • Vaginal • Total Laparoscopic • Laparoscopic assisted • Extent • Total • Subtotal • Supracervical • Diagnosis 3 3/28/2016 CPT Codes • Abdominal 58150 – • With or without removal tubes/ovaries 58240 • Some additional services • Vaginal 58260-58270 • Size of uterus < 250 grams, > 250 grams 58275-58294 • Additional services CPT Codes • LAVH 58541-58544 • Detach uterus , cervix, and structures through the scope 58548-58554 • Uterus removed thru the vagina • TLH • Detach structures laparoscopically entire 58570- 58573 uterus, cervix, bodies • Removed thru the vagina or abdomen • LSH • Detaching structures through the scope, 58541 – 58544 leaving the cervix • Morcellating – removing abdominally 4 3/28/2016 Hysterectomy Additional procedures performed • Tubes & Ovaries removed • Enterocele repair • Repairs for incontinence • Marshall-Marchetti-Krantz • Colporrhaphy • Colpo-urethropexy • Urethral Sling • TVT, TOT 5 3/28/2016 Procedures • 57288 Sling • 57240 Anterior Repair • 57250 Posterior Repair • +57267 Add on code for mesh/graft • 57260 Combo of A&P • 57425 Laparoscopic Colpopexy • 57280 Colpopexy, Abdominal approach • 57282 Colpopexy, vaginal approach Example 1 PREOPERATIVE DIAGNOSES: 1. Menorrhagia unresponsive to medical treatment with resulting chronic blood loss anemia POSTOPERATIVE DIAGNOSES: 1. Menorrhagia 2. Blood loss anemia TITLE OF SURGERY: Total abdominal hysterectomy ANESTHESIA: GENERAL ENDOTRACHEAL ANESTHESIA. INDICATIONS: The patient is a lovely 52-year-old female who presented with menorrhagia that is non- responsive to medical treatment.
    [Show full text]
  • Gynecological-DBQ
    INTERNAL VETERANS AFFAIRS USE GYNECOLOGICAL CONDITIONS DISABILITY BENEFITS QUESTIONNAIRE IMPORTANT - THE DEPARTMENT OF VETERANS AFFAIRS (VA) WILL NOT PAY OR REIMBURSE ANY EXPENSES OR COST INCURRED IN THE PROCESS OF COMPLETING AND/OR SUBMITTING THIS FORM. PLEASE READ THE PRIVACY ACT AND RESPONDENT BURDEN INFORMATION ON REVERSE BEFORE COMPLETING FORM. NAME OF PATIENT/VETERAN PATIENT/VETERAN'S SOCIAL SECURITY NUMBER NOTE TO PHYSICIAN - Your patient is applying to the U.S. Department of Veterans Affairs (VA) for disability benefits. VA will consider the information you provide on this questionnaire as part of their evaluation in processing the claim. VA reserves the right to confirm the authenticity of ALL DBQs completed by private health care providers. IS THIS DBQ BEING COMPLETED IN CONJUNCTION WITH A VA21-2507, C&P EXAMINATION REQUEST? YES NO If no, how was the examination completed (check all that apply)? In-person examination Records reviewed Other, please specify: Comments: ACCEPTABLE CLINICAL EVIDENCE (ACE) INDICATE METHOD USED TO OBTAIN MEDICAL INFORMATION TO COMPLETE THIS DOCUMENT: Review of available records (without in-person or video telehealth examination) using the Acceptable Clinical Evidence (ACE) process because the existing medical evidence provided sufficient information on which to prepare the DBQ and such an examination will likely provide no additional relevant evidence. Review of available records in conjunction with a telephone interview with the Veteran (without in-person or telehealth examination) using the ACE process because the existing medical evidence supplemented with a telephone interview provided sufficient information on which to prepare the DBQ and such an examination would likely provide no additional relevant evidence.
    [Show full text]
  • Orphanet Report Series Rare Diseases Collection
    Marche des Maladies Rares – Alliance Maladies Rares Orphanet Report Series Rare Diseases collection DecemberOctober 2013 2009 List of rare diseases and synonyms Listed in alphabetical order www.orpha.net 20102206 Rare diseases listed in alphabetical order ORPHA ORPHA ORPHA Disease name Disease name Disease name Number Number Number 289157 1-alpha-hydroxylase deficiency 309127 3-hydroxyacyl-CoA dehydrogenase 228384 5q14.3 microdeletion syndrome deficiency 293948 1p21.3 microdeletion syndrome 314655 5q31.3 microdeletion syndrome 939 3-hydroxyisobutyric aciduria 1606 1p36 deletion syndrome 228415 5q35 microduplication syndrome 2616 3M syndrome 250989 1q21.1 microdeletion syndrome 96125 6p subtelomeric deletion syndrome 2616 3-M syndrome 250994 1q21.1 microduplication syndrome 251046 6p22 microdeletion syndrome 293843 3MC syndrome 250999 1q41q42 microdeletion syndrome 96125 6p25 microdeletion syndrome 6 3-methylcrotonylglycinuria 250999 1q41-q42 microdeletion syndrome 99135 6-phosphogluconate dehydrogenase 67046 3-methylglutaconic aciduria type 1 deficiency 238769 1q44 microdeletion syndrome 111 3-methylglutaconic aciduria type 2 13 6-pyruvoyl-tetrahydropterin synthase 976 2,8 dihydroxyadenine urolithiasis deficiency 67047 3-methylglutaconic aciduria type 3 869 2A syndrome 75857 6q terminal deletion 67048 3-methylglutaconic aciduria type 4 79154 2-aminoadipic 2-oxoadipic aciduria 171829 6q16 deletion syndrome 66634 3-methylglutaconic aciduria type 5 19 2-hydroxyglutaric acidemia 251056 6q25 microdeletion syndrome 352328 3-methylglutaconic
    [Show full text]